BEIJING — Here are the latest developments on the novel coronavirus disease (COVID-19) in China:

— The city of Suifenhe, at the China-Russia border in Northeast China's Heilongjiang province, reported a total of 322 confirmed COVID-19 cases from overseas and 38 asymptomatic infections by April 13, local epidemic prevention and control authorities said on April 14.

— The temporary hospital in Suifenhe has been ready for use as the number of imported COVID-19 cases keeps rising. Acting mayor Wang Yongping said the hospital, converted from an office building, will provide 600 beds for asymptomatic cases and patients with mild symptoms.

Some 400 medics from medical facilities of the Mudanjiang city have been sent to Suifenhe, which is under the jurisdiction of Mudanjiang, preparing for carrying out treatment in the hospital.

— Suifenhe on April 13 put a mobile laboratory into use, which greatly improves the city's nucleic acid testing capability. So far, the city's daily testing capability has exceeded 1,000.

— China has approved three COVID-19 vaccine candidates for clinical trials, said an official with the Ministry of Science and Technology on April 14.

An adenovirus vector vaccine, developed by a research team led by Chen Wei with the Institute of Military Medicine under the Academy of Military Sciences, was the first to be approved to enter clinical trial. It is the first COVID-19 vaccine in the world that has entered the second phase of clinical trial, according to the World Health Organization.

— A Chinese health official on April 14 said effective prevention measures against the novel coronavirus should be maintained as several new domestic cases were reported in the country.

Several provincial-level regions have reported domestic cases or asymptomatic carriers over the past consecutive days, thus effective personal protection and community-based control and prevention measures should be maintained, said Mi Feng with the National Health Commission at a press conference.

— China has issued a technical guideline for universities and colleges nationwide to reopen in an orderly manner on the premise that local COVID-19 epidemic is well tamed.

Students will return to campuses after they receive a notice, said the guideline jointly released by the National Health Commission and the Ministry of Education on April 13, aiming to minimize risks and ensure the safety and health of students and faculty members.

— Traditional Chinese medicine (TCM) has proved to be effective in treating convalescent COVID-19 patients in their rehabilitation, said Li Yu, an official with the National Administration of Traditional Chinese Medicine, on April 14.

Chinese health authorities also issued a guideline on the use of TCM for convalescent individuals in February, including TCM prescriptions, diet guidance, moxibustion, cupping, acupuncture, and music therapies, as well as traditional exercises such as tai chi.

— Chinese health authority received reports of 89 new confirmed COVID-19 cases on the Chinese mainland on April 13, of which 86 were imported.

Three new domestically transmitted cases were reported, all in Guangdong province, the National Health Commission said.

Three new suspected cases, all imported ones, were reported on April 13 on the mainland, with two in Shanghai and one in Inner Mongolia autonomous region.

— China's Hubei province reported no new confirmed COVID-19 cases and no new deaths on April 13.

The province had 610 asymptomatic cases under medical observation by April 13, including 22 such cases that were reported on April 13.

— Northeast China's Heilongjiang province bordering Russia reported 79 new confirmed COVID-19 cases on April 13.

All of them were Chinese nationals returning from Russia. Of them, 65 were previously asymptomatic cases.